推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 國家食品藥品監(jiān)督管理總局日前發(fā)布中西藥復(fù)方制劑不良反應(yīng)信息通報，提示患者、醫(yī)務(wù)人員關(guān)注感冒清片(膠囊)、腦絡(luò)通膠囊等中西藥復(fù)方制劑所引起的不良反應(yīng)。
通報顯示，感冒清片(膠囊)主要用于治療風(fēng)熱感冒引起的發(fā)燒，咽喉腫痛等癥狀。組方中含有對乙酰氨基酚等3種化藥成分，及大青葉、崗梅等6種中藥成分。監(jiān)測數(shù)據(jù)顯示，其引起的不良反應(yīng)為血尿等；在與含有相同成分或功效類似的藥品聯(lián)合使用時，可能會增加其嚴(yán)重不良反應(yīng)風(fēng)險。
而用于治療腦血栓、中風(fēng)后遺癥等引起的頭痛、眩暈、半身不遂等癥狀的腦絡(luò)通膠囊，存在引起過敏反應(yīng)的風(fēng)險。其組方中含有鹽酸托哌酮、維生素B6、川芎浸膏等。監(jiān)測數(shù)據(jù)顯示，腦絡(luò)通膠囊的過敏反應(yīng)可能主要與其鹽酸托哌酮組分有關(guān)。
總局建議，相關(guān)生產(chǎn)企業(yè)應(yīng)盡快完善藥品說明書的安全性信息，增加或修訂警示語、不良反應(yīng)、注意事項(xiàng)、禁忌、特殊人群用藥及藥物相互作用等項(xiàng)內(nèi)容，降低用藥風(fēng)險。
